# Cannabidiol in Opioid Use Disorder and Chronic Pain

> **NCT04587791** · EARLY_PHASE1 · RECRUITING · sponsor: **Yale University** · enrollment: 34 (estimated)

## Conditions studied

- Chronic Pain
- Opioid Use Disorder

## Interventions

- **DRUG:** 400 mg Cannabidiol
- **DRUG:** 800 mg Cannabidiol
- **DRUG:** 1200 mg Cannabidiol
- **DRUG:** Beta carotene oral solution without CBD

## Key facts

- **NCT ID:** NCT04587791
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-12-08
- **Primary completion:** 2026-08-31
- **Final completion:** 2026-08-31
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2026-04-14

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04587791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04587791, "Cannabidiol in Opioid Use Disorder and Chronic Pain". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04587791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*